Diquafosol Ophthalmic Solution Increases Pre- and Postlens Tear Film During Contact Lens Wear in Rabbit Eyes
- PMID: 27243352
- DOI: 10.1097/ICL.0000000000000283
Diquafosol Ophthalmic Solution Increases Pre- and Postlens Tear Film During Contact Lens Wear in Rabbit Eyes
Abstract
Objectives: To investigate the behavior of prelens tear film (PLTF) and postlens tear film (PoLTF) after the instillation of diquafosol using an experimental rabbit model of eyes with contact lens.
Methods: Cross-sectional, anterior segment optical coherence tomographic images of the inferior midperipheral cornea were obtained at baseline and at 5, 15, 30, 60, 90, and 120 min after the instillation of 3% diquafosol ophthalmic solution in 10 Japanese white rabbits wearing contact lenses. From the obtained images, the areas of the PLTF and PoLTF were calculated. Both artificial tear solution and 0.1% sodium hyaluronate ophthalmic solution were used for comparison.
Results: Significant fluid accumulation in both the PLTF and PoLTF was observed after diquafosol instillation, whereas no fluid accumulation was visible after the instillation of artificial tear or sodium hyaluronate. The increase in PLTF area after diquafosol instillation was significantly higher (P<0.01) at 15 and 30 min than that after the instillation of artificial tear or sodium hyaluronate. The increase in PoLTF area up to 60 min after the instillation of diquafosol was significantly higher (P<0.01) than that after the instillation of either of the other two drugs.
Conclusions: Instillation of 3% diquafosol ophthalmic solution increases PLTF and PoLTF in rabbit eyes with contact lenses. Diquafosol has potential as a treatment option for contact lens-related dry eye.
Similar articles
-
Prominent Decrease of Tear Meniscus Height With Contact Lens Wear and Efficacy of Eye Drop Instillation.Eye Contact Lens. 2015 Sep;41(5):318-22. doi: 10.1097/ICL.0000000000000134. Eye Contact Lens. 2015. PMID: 25839348
-
Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.Korean J Ophthalmol. 2017 Aug;31(4):306-312. doi: 10.3341/kjo.2016.0056. Epub 2017 Jul 13. Korean J Ophthalmol. 2017. PMID: 28752695 Free PMC article. Clinical Trial.
-
Evaluation of Tear Meniscus Dynamics Using Anterior Segment Swept-Source Optical Coherence Tomography After Topical Solution Instillation for Dry Eye.Cornea. 2016 May;35(5):654-8. doi: 10.1097/ICO.0000000000000807. Cornea. 2016. PMID: 26989953
-
Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.Drugs. 2015 May;75(8):911-22. doi: 10.1007/s40265-015-0409-7. Drugs. 2015. PMID: 25968930 Review.
-
Diquafosol ophthalmic solution for dry eye treatment.Adv Ther. 2012 Jul;29(7):579-89. doi: 10.1007/s12325-012-0033-9. Epub 2012 Jul 27. Adv Ther. 2012. PMID: 22843206 Review.
Cited by
-
The Effect of Diquafosol Ophthalmic Solution on Clinical Parameters and Visual Function in Soft Contact Lens-Related Dry Eye.Adv Ther. 2021 Nov;38(11):5534-5547. doi: 10.1007/s12325-021-01910-8. Epub 2021 Sep 29. Adv Ther. 2021. PMID: 34590267 Clinical Trial.
-
Applications of Diquafosol Sodium in Ophthalmology: A Comprehensive Review of Therapeutic Utility.Life (Basel). 2025 Mar 17;15(3):484. doi: 10.3390/life15030484. Life (Basel). 2025. PMID: 40141828 Free PMC article. Review.
-
Contact Lenses Loaded with Melatonin Analogs: A Promising Therapeutic Tool against Dry Eye Disease.J Clin Med. 2022 Jun 17;11(12):3483. doi: 10.3390/jcm11123483. J Clin Med. 2022. PMID: 35743553 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical